[ad_1]
Dr. Reddy’s Laboratories Ltd., included within the 12 months 1984, is a Giant Cap firm (having a market cap of Rs 78690.00 Crore) working in Prescription drugs sector.
Dr. Reddy’s Laboratories Ltd. key Merchandise/Income Segments embrace Prescription drugs, Licence Charges, Different Working Income, Spent Chemical compounds, Service Earnings and Scrap for the 12 months ending 31-Mar-2021.
Financials
For the quarter ended 30-09-2021, the corporate reported a Consolidated Complete Earnings of Rs 5992.40 Crore, up 18.59 % from final quarter Complete Earnings of Rs 5053.00 Crore and up 20.76 % from final 12 months identical quarter Complete Earnings of Rs 4962.10 Crore. Firm reported web revenue after tax of Rs 971.10 Crore in newest quarter.
Funding Rationale
Reversed sharply after forming the Hammer candlestick sample close to the necessary retracement zone
Promoter/FII Holdings
Promoters held 26.72 per cent stake within the firm as of 30-Sep-2021, whereas FIIs owned 27.76 per cent, DIIs 21.4 per cent.
(Disclaimer: Suggestions given on this part or any reviews connected herein are authored by an exterior occasion. Views expressed are that of the respective authors/entities. These don’t symbolize the views of Financial Occasions (ET). ET doesn’t assure, vouch for, endorse any of its contents and hereby disclaims all warranties, categorical or implied, regarding the identical. Please seek the advice of your monetary adviser and search unbiased recommendation.
[ad_2]
Source link